# TOPIC_LABELING_ARTWORK.md — Review Report

**Phase:** 5.2-N — Draft Review Before Implementation
**Date:** 2026-05-08
**Reviewer:** Design Partner (automated + manual review)
**Status:** Draft review complete — pending Brian / ISC acceptance

---

## 1. Review Status

```
Status: Draft review complete — pending Brian / ISC acceptance
```

The review assessed `TOPIC_LABELING_ARTWORK.md` against the approved topic page template, the Stage 3 classification packet, the topic content production protocol, and existing implemented topic precedents (`TOPIC_PACKAGING.md`, `TOPIC_SERIALIZATION.md`).

---

## 2. Source Documents Reviewed

| Document | Role in review |
|---|---|
| `TOPIC_LABELING_ARTWORK.md` | Subject of review (420 lines) |
| `TOPIC_LABELING_ARTWORK_STAGE_3_REVIEW.md` | Classification source-of-truth (128 classified rows) |
| `TOPIC_LABELING_ARTWORK_DRAFT_PACKET.md` | Stage 2 source reference |
| `TOPIC_CONTENT_PRODUCTION_PROTOCOL.md` | Protocol compliance reference |
| `TOPIC_PAGE_TEMPLATE.md` | Template conformance reference |
| `TOPIC_PACKAGING.md` | Structural precedent |
| `TOPIC_SERIALIZATION.md` | Structural precedent |

---

## 3. Template Conformance Review

### Five Public Sections

| Section | Required Title | Actual Title | Line | Present | Correct Order |
|---|---|---|---|---|---|
| 1 | What this is | What This Is | 56 | ✅ | ✅ |
| 2 | Ownership boundaries | Ownership Boundaries | 79 | ✅ | ✅ |
| 3 | Applicability | Applicability | 140 | ✅ | ✅ |
| 4 | Regulatory chain | Regulatory Chain | 241 | ✅ | ✅ |
| 5 | What it touches next | What It Touches Next | 281 | ✅ | ✅ |

**Result:** ✅ All five public sections present in correct order.

### Non-Public / Control Sections

| Section | Present |
|---|---|
| Document control (header) | ✅ |
| Implementation hold notice | ✅ |
| Topic header | ✅ |
| 90-second scan | ✅ |
| Context-specific display notes | ✅ |
| Internal notes not for public display | ✅ |
| Source gaps withheld from public copy | ✅ |
| Implementation notes | ✅ |
| Acceptance criteria | ✅ |
| Stage gate | ✅ |
| Governance notice | ✅ |

**Result:** ✅ All required control sections present.

### Template Structure Issues

None identified.

---

## 4. Classification Conformance Review

### Row Utilization Summary

| Classification | Stage 3 Count | Handling in Draft |
|---|---|---|
| Approved (92 rows) | 92 | Used as primary source material for public sections |
| Revise (21 rows) | 21 | Used through reviewer-note reframes only |
| Keep internal (6 rows) | 6 | Not used directly; public-safe Common Pitfall rewrites used where provided |
| Source gap (8 rows) | 8 | Withheld from public copy; listed in Source Gaps section |
| Exclude (1 row) | 1 | Not used; noted in Source Gaps section |

### Section-Level Mapping

| Public Section | Primary Classification Source |
|---|---|
| Section 1 — What This Is | Approved rows (definition, scope, barcode coexistence) + 1 public-safe Common Pitfall rewrite from Keep internal |
| Section 2 — Ownership Boundaries | Approved rows (ownership table, decision rights, handoffs) + Revise reframes (MAH/NDA accountability, CDMO QA boundaries) |
| Section 3 — Applicability | Approved rows (US/EU comparison, entity roles) + Revise reframes (preclinical, lifecycle stages, old-stock exhaustion) |
| Section 4 — Regulatory Chain | Approved rows (source chain, key sources table) |
| Section 5 — What It Touches Next | Approved rows (connected topics, handoffs) + 3 public-safe Common Pitfall rewrites from Keep internal |

**Result:** ✅ Classification rules followed at section level. No suspected violations.

---

## 5. Revise-Row Handling Review

The following high-attention Revise rows were verified:

| Revise Theme | Original Strong Wording | Draft Wording | Verdict |
|---|---|---|---|
| NDA Holder / MAH responsibility | "ultimate legal responsibility" | "accountability typically includes ensuring the physical label aligns with the dossier approved by the agency" (L191) | ✅ Softened |
| CDMO Quality Agreement | "must explicitly define" | "Quality Agreements between MAH / NDA holder and CDMO typically specify who verifies…" (L94) | ✅ Softened |
| Preclinical not applicable | "not applicable" | "usually not central in preclinical, when bench-stage product is governed by laboratory or research-use labeling instead" (L225) | ✅ Softened |
| Late-stage clinical must comply | "must comply" | "typically governed by EudraLex Volume 4 Annex 13 (EU) and 21 CFR 312.6 (US)" (L229) | ✅ Softened |
| Pack-line validation must be complete | "must be complete" | "typically expected to be complete before first commercial production" (L233) | ✅ Softened |
| Returns / Recalls leading cause | "leading cause" | "frequently cited cause" (L290) | ✅ Softened |
| Old label inventory exhaustion | Misbranding determination | "can result in distribution that may be treated as misbranded" (L237) | ✅ Softened — uses "may be treated as" rather than making a legal determination |

**Result:** ✅ All high-attention Revise rows use reviewer-note reframes. No absolute legal determinations found.

---

## 6. Keep-Internal Handling Review

### Adversarial Language Scan

Automated search for the following phrases in public-facing sections (lines 56–327):

| Phrase | Found in Public Sections |
|---|---|
| "direct violation" | ❌ Not found |
| "fast track to a 483" | ❌ Not found |
| "liable" | ❌ Not found |
| "adulterated" | ❌ Not found |
| "misbranded product" | ❌ Not found |
| "critical violation" | ❌ Not found |
| "violates ALCOA+" | ❌ Not found |

**Note:** The phrase "misbranded" appears once in public Section 3C (L237) as "may be treated as misbranded under FD&C Act §502." This is the approved Revise-row reframe — it uses conditional language ("may be treated as") and cites the statutory anchor. This is consistent with the reviewer-note reframe and does not constitute raw adversarial language.

The phrase "direct violation" and others appear only on L355 within the non-public "Internal Notes Not for Public Display" section, where they are listed as terms that were *not* used. This is the expected disclosure.

### Public-Safe Common Pitfall Rewrites

| Pitfall | Section | Source | Verdict |
|---|---|---|---|
| Color drift / draw-down pitfall | Section 1 (L75) | ALCOA+ Keep-internal → public-safe rewrite | ✅ Orientation tone |
| ERP cut-over / in-transit WIP | Section 5 (L305) | NotebookLM Keep-internal → public-safe rewrite | ✅ Orientation tone |
| Supplier COA vs. incoming inspection | Section 5 (L306) | NotebookLM Keep-internal → public-safe rewrite | ✅ Orientation tone |
| Vision-system validation | Section 5 (L307) | NotebookLM Keep-internal → public-safe rewrite | ✅ Orientation tone |

**Result:** ✅ No adversarial language leaked into public sections. Only public-safe Common Pitfall rewrites used.

---

## 7. Source-Gap Handling Review

8 Source gap themes are listed in the "Source Gaps Withheld From Public Copy" section (L359–374).

| Source Gap Theme | Appears in Public Copy | Appears in Withheld Section |
|---|---|---|
| Bright stock controls | ❌ | ✅ |
| Barcode grading liability | ❌ | ✅ |
| Vision-system validation evidence | ❌ | ✅ |
| Artwork vault status | ❌ | ✅ |
| Roll-splicing controls | ❌ | ✅ |
| Late-breaking PI changes | ❌ | ✅ |
| Multi-language EU clusters | ❌ | ✅ |
| Post-Nov 2024 enforcement landscape | ❌ | ✅ |

**Result:** ✅ All Source gap themes are withheld from public copy and properly documented.

---

## 8. Exclude-Row Handling Review

Excluded items:

| Excluded Item | Appears in Public Copy | Appears in Withheld Section |
|---|---|---|
| Health Canada (GUI-0001) | ❌ | ✅ (L372 — excluded note) |
| ANVISA (RDC No. 301) | ❌ | ✅ (L372 — excluded note) |

**Result:** ✅ Excluded content does not appear in public sections.

---

## 9. Source / Citation Posture Review

| Check | Result |
|---|---|
| No source records added to app | ✅ |
| No citations added to app data | ✅ |
| Source references used only as draft topic-file content | ✅ |
| Citation-format review noted as required before implementation | ✅ (L277) |
| No claim of independent source verification | ✅ (L374) |

**Result:** ✅ Source/citation posture is correct.

---

## 10. Public-Facing Wording Review

| Check | Result |
|---|---|
| Senior-leader orientation tone | ✅ Consistent throughout |
| Source-backed but not legalistic | ✅ References cite regulations without making legal determinations |
| No compliance scoring | ✅ Not found |
| No legal determination language | ✅ Not found |
| No "required / not required" applicability determinations | ✅ Not found |
| No public audit/governance/workflow language | ✅ Not found |

### "Must" Usage in Public Sections

4 instances of "must" found in public sections (L65, L70, L136, L299). All are used in descriptive/operational context:

- L65: "that must be specified, produced, inspected, and reconciled" — describes what a printed component is
- L70: "that must be legible" — describes what HR text is
- L136: "the artwork master must flow through…" — describes a process sequence
- L299: "must align with packaging schedule" — describes an operational dependency

None are used as legal requirements or compliance determinations. These are within the accepted tone for senior-leader orientation.

**Result:** ✅ Wording is appropriate for public-facing orientation content.

---

## 11. Implementation Readiness Review

| Readiness Check | Result |
|---|---|
| Five public sections present and in order | ✅ |
| Classification rules followed | ✅ |
| Adversarial language excluded from public sections | ✅ |
| Source gaps withheld | ✅ |
| Exclude rows excluded | ✅ |
| Revise rows use reframes | ✅ |
| Source/citation posture correct | ✅ |
| Tone appropriate | ✅ |
| Implementation hold notice present | ✅ |
| Stage gate present | ✅ |
| No app code changed | ✅ |
| `/topics/labeling-artwork` not populated | ✅ |

**Result:** ✅ Ready for Brian / ISC approval.

---

## 12. Issues Found

**None.**

No blockers, no classification violations, no adversarial leaks, no source-gap breaches, no excluded-jurisdiction content in public sections, no legal determination language, no compliance scoring.

---

## 13. Required Corrections

**None.**

---

## 14. Recommendation

```
Ready for Brian / ISC approval.
```

`TOPIC_LABELING_ARTWORK.md` passes all review checks. No corrections are required before proceeding to Brian / ISC final acceptance.

After Brian / ISC acceptance, the topic may proceed to implementation in a subsequent phase.

---

## 15. Stage Gate

| Field | Value |
|---|---|
| Topic | Labeling & Artwork |
| Review file | `TOPIC_LABELING_ARTWORK_REVIEW_REPORT.md` |
| Subject file | `TOPIC_LABELING_ARTWORK.md` |
| Status | Draft review complete — pending Brian / ISC acceptance |
| Stage | 5.2-N — Draft Review Before Implementation |
| Issues | None |
| Blockers | None |
| Corrections required | None |
| Recommendation | Ready for Brian / ISC approval |
| Next phase | Brian / ISC acceptance → Implementation phase |

---

> **Governance Notice:** This review report is a controlled quality-gate document. It does not constitute approval for implementation. Brian / ISC must separately accept the draft topic file before any public implementation occurs.
